1-3 of 3
José García-Laraña
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation

Clinical Trials & Observations
Joaquin Martinez-Lopez, Joan Blade, María-Victoria Mateos, Carlos Grande, Adrián Alegre, José García-Laraña, Anna Sureda, Javier de la Rubia, Eulogio Conde, Rafael Martinez, Felipe de Arriba, Maria C. Viguria, Joan Besalduch, Rafael Cabrera, José D. Gonzalez-San Miguel, José Luis Guzman-Zamudio, Maria Carmen Gomez del Castillo, José Maria Moraleda, Juan C. García-Ruiz, Jesús San Miguel, Juan José Lahuerta, for the GEM (Grupo Español de MM) and PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatía Maligna) Cooperative Study Groups
Journal: Blood
Blood (2011) 118 (3): 529–534.
https://doi.org/10.1182/blood-2011-01-332320
Published: 2011
Journal Articles

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

e-blood
Beatriz Sánchez-Espiridión, Carlos Montalbán, Ángel López, Javier Menárguez, Pilar Sabín, Carmen Ruiz-Marcellán, Andrés Lopez, Rafael Ramos, Jose Rodríguez, Araceli Cánovas, Carmen Camarero, Miguel Canales, Javier Alves, Reyes Arranz, Agustín Acevedo, Antonio Salar, Sergio Serrano, Águeda Bas, Jose M. Moraleda, Pedro Sánchez-Godoy, Fernando Burgos, Concepción Rayón, Manuel F. Fresno, José García Laraña, Mónica García-Cosío, Carlos Santonja, Jose L. López, Marta Llanos, Manuela Mollejo, Joaquín González-Carrero, Ana Marín, Jerónimo Forteza, Ramón García-Sanz, Jose F. Tomás, Manuel M. Morente, Miguel A. Piris, Juan F. García, on behalf of the Spanish Hodgkin Lymphoma Study Group
Journal: Blood
Blood (2010) 116 (8): e12–e17.
https://doi.org/10.1182/blood-2010-02-270009
Published: 2010
Journal Articles

Tandem Autologous Transplant Versus Reduced Intensity Conditioned Allogeneic Transplant (Allo-RIC) as Second Intensification in Chemosensitive Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.

Joan Blade, MD, Laura Rosinol, MD, Juan Jose Lahuerta, MD, Anna Sureda, MD, Javier de la Rubia, MD, Jose Garcia-Larana, MD, Miguel Hernandez-Garcia, MD, Belen Hernandez-Ruiz, MD, Jose Antonio Perez-Simon, MD, Jose Luis Bello, MD, Dolores Carrera, MD, Maria Jesus Penarrubia, MD, Eugenia Abella, MD, Angel Leon, MD, Concepcion Poderos, MD, Juan Carlos Garcia-Ruiz, MD, Joan Besalduch, MD, Rafael Martinez-Martinez, MD, Isabel Perez-Fernandez, MD, Paz Ribas, MD, Jesus San Miguel, MD
Journal: Blood
Blood (2007) 110 (11): 729.
https://doi.org/10.1182/blood.V110.11.729.729
Published: 2007